×

Sie nutzen einen Browser, der für diese Website nicht mehr unterstützt wird.
Bitte nutzen Sie die neueste Version von Chrome, Firefox, Edge oder Safari.

Newsroom

Hier finden Sie unsere News in chronologischer Reihenfolge

2023

LinkedIn

Fontan Patient Luca

"Simply put, without the "Berlin Heart", he would have died two or three days later."

Words of a mother who almost lost her child.

Her son Luca, who was born with a univentricular heart and suffered from a failing Fontan circulation, was saved by the EXCOR® Revive Ventricular Assistant Device System.

Luca, 17 at the time, needed a heart transplant but was removed from the list due to Fontan palliation issues. He was weak, immobile, and had severe health problems. With his doctors and family, Luca opted for EXCOR® Revive, which significantly improved his condition. He made it back on the transplant list and became increasingly active. After 132 days on EXCOR® Revive, he successfully received a donor heart.

In 2022´s Berlin Heart summer event, we had the great honor to celebrate with Luca and his family. We also showed them around our production facilities and had the opportunity to talk about his experience with the “Berlin Heart”.

See the moving interview below and on Youtube: https://lnkd.in/dsFAMZ-i

#failingfontan #ourpatientsourmission #VAD

LMU Klinikum München, Fontanherzen eV, Steffi Sänger, Oliver Päßler, BIOCOM Interrelations GmbH

++++++++++

The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only.
 
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.

LinkedIn

Fontan Patient Luca

"Simply put, without the "Berlin Heart", he would have died two or three days later."

Words of a mother who almost lost her child.

Her son Luca, who was born with a univentricular heart and suffered from a failing Fontan circulation, was saved by the EXCOR® Revive Ventricular Assistant Device System.

Luca, 17 at the time, needed a heart transplant but was removed from the list due to Fontan palliation issues. He was weak, immobile, and had severe health problems. With his doctors and family, Luca opted for EXCOR® Revive, which significantly improved his condition. He made it back on the transplant list and became increasingly active. After 132 days on EXCOR® Revive, he successfully received a donor heart.

In 2022´s Berlin Heart summer event, we had the great honor to celebrate with Luca and his family. We also showed them around our production facilities and had the opportunity to talk about his experience with the “Berlin Heart”.

See the moving interview below and on Youtube: https://lnkd.in/dsFAMZ-i

#failingfontan #ourpatientsourmission #VAD

LMU Klinikum München, Fontanherzen eV, Steffi Sänger, Oliver Päßler, BIOCOM Interrelations GmbH

++++++++++

The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only.
 
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.

LinkedIn

Fontan Patient Luca

"Simply put, without the "Berlin Heart", he would have died two or three days later."

Words of a mother who almost lost her child.

Her son Luca, who was born with a univentricular heart and suffered from a failing Fontan circulation, was saved by the EXCOR® Revive Ventricular Assistant Device System.

Luca, 17 at the time, needed a heart transplant but was removed from the list due to Fontan palliation issues. He was weak, immobile, and had severe health problems. With his doctors and family, Luca opted for EXCOR® Revive, which significantly improved his condition. He made it back on the transplant list and became increasingly active. After 132 days on EXCOR® Revive, he successfully received a donor heart.

In 2022´s Berlin Heart summer event, we had the great honor to celebrate with Luca and his family. We also showed them around our production facilities and had the opportunity to talk about his experience with the “Berlin Heart”.

See the moving interview below and on Youtube: https://lnkd.in/dsFAMZ-i

#failingfontan #ourpatientsourmission #VAD

LMU Klinikum München, Fontanherzen eV, Steffi Sänger, Oliver Päßler, BIOCOM Interrelations GmbH

++++++++++

The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only.
 
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.

LinkedIn

Fontan Patient Luca

"Simply put, without the "Berlin Heart", he would have died two or three days later."

Words of a mother who almost lost her child.

Her son Luca, who was born with a univentricular heart and suffered from a failing Fontan circulation, was saved by the EXCOR® Revive Ventricular Assistant Device System.

Luca, 17 at the time, needed a heart transplant but was removed from the list due to Fontan palliation issues. He was weak, immobile, and had severe health problems. With his doctors and family, Luca opted for EXCOR® Revive, which significantly improved his condition. He made it back on the transplant list and became increasingly active. After 132 days on EXCOR® Revive, he successfully received a donor heart.

In 2022´s Berlin Heart summer event, we had the great honor to celebrate with Luca and his family. We also showed them around our production facilities and had the opportunity to talk about his experience with the “Berlin Heart”.

See the moving interview below and on Youtube: https://lnkd.in/dsFAMZ-i

#failingfontan #ourpatientsourmission #VAD

LMU Klinikum München, Fontanherzen eV, Steffi Sänger, Oliver Päßler, BIOCOM Interrelations GmbH

++++++++++

The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only.
 
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.

LinkedIn

Fontan Patient Luca

"Simply put, without the "Berlin Heart", he would have died two or three days later."

Words of a mother who almost lost her child.

Her son Luca, who was born with a univentricular heart and suffered from a failing Fontan circulation, was saved by the EXCOR® Revive Ventricular Assistant Device System.

Luca, 17 at the time, needed a heart transplant but was removed from the list due to Fontan palliation issues. He was weak, immobile, and had severe health problems. With his doctors and family, Luca opted for EXCOR® Revive, which significantly improved his condition. He made it back on the transplant list and became increasingly active. After 132 days on EXCOR® Revive, he successfully received a donor heart.

In 2022´s Berlin Heart summer event, we had the great honor to celebrate with Luca and his family. We also showed them around our production facilities and had the opportunity to talk about his experience with the “Berlin Heart”.

See the moving interview below and on Youtube: https://lnkd.in/dsFAMZ-i

#failingfontan #ourpatientsourmission #VAD

LMU Klinikum München, Fontanherzen eV, Steffi Sänger, Oliver Päßler, BIOCOM Interrelations GmbH

++++++++++

The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only.
 
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.

LinkedIn

Fontan Patient Luca

"Simply put, without the "Berlin Heart", he would have died two or three days later."

Words of a mother who almost lost her child.

Her son Luca, who was born with a univentricular heart and suffered from a failing Fontan circulation, was saved by the EXCOR® Revive Ventricular Assistant Device System.

Luca, 17 at the time, needed a heart transplant but was removed from the list due to Fontan palliation issues. He was weak, immobile, and had severe health problems. With his doctors and family, Luca opted for EXCOR® Revive, which significantly improved his condition. He made it back on the transplant list and became increasingly active. After 132 days on EXCOR® Revive, he successfully received a donor heart.

In 2022´s Berlin Heart summer event, we had the great honor to celebrate with Luca and his family. We also showed them around our production facilities and had the opportunity to talk about his experience with the “Berlin Heart”.

See the moving interview below and on Youtube: https://lnkd.in/dsFAMZ-i

#failingfontan #ourpatientsourmission #VAD

LMU Klinikum München, Fontanherzen eV, Steffi Sänger, Oliver Päßler, BIOCOM Interrelations GmbH

++++++++++

The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR Active are intended for professional healthcare facility environments only.
 
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.